Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Regen Addresses Potential Impact of Bristol Myers Squibb's $2.3 Billion Acquisition of IFM

americanpharmaceuticalreviewAugust 11, 2017

Tag: small molecules , IFM , Bristol Myers Squibb

PharmaSources Customer Service